Skip to content

Complete Blood Count (CBC) Test

Published: August 9, 2026Updated: August 15, 2026

A laboratory test that measures the amount of bedaquiline, an antibiotic used to treat drug-resistant tuberculosis, in your blood to ensure proper dosing and monitor treatment effectiveness.

Quick summary

{"Measures bedaquiline concentration in blood serum or plasma","Helps doctors ensure you receive the right dose for effective tuberculosis treatment","Used specifically for treating multidrug-resistant tuberculosis (MDR-TB)","Blood sample is typically collected before taking your morning dose","Results help prevent side effects and ensure optimal treatment outcomes"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 15, 2026Editorial policy

Key facts at a glance

LOINC
80637-2
Short code
BDQ
Synonyms
Bedaquiline SerPl-mCnc
Category
chemistry
Sample
serum
Container
Red-top serum collection tube (no anticoagulant) or serum separator tube (SST)
Units
N/A
Ref low
0.3
Ref high
3
Critical range
— – 5 N/A
Fasting
false
Population
adult
Sex
all
Age range
18–99 years
Method
Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
CPT
80299
SNOMED
444455005
Specimen volume
2 mL serum
Stability
Room temperature: 8 hours; Refrigerated (2–8°C): 7 days; Frozen (-20°C or below): 30 days. Avoid repeated freeze-thaw cycles.
Hemolysis max
100
Lipemia max
150
Icterus max
50
TAT
48–120 hours
Order
routine

The complete blood count, or CBC, is a routine blood test that measures the different cells in your blood, including red blood cells, white blood cells, and platelets. It gives your doctor a broad picture of your overall health and can help detect a wide range of conditions, from infections and anemia to blood disorders.

The bedaquiline test measures how much of the antibiotic medication called bedaquiline is present in your blood serum or plasma. Bedaquiline is a specialized antibiotic used to treat multidrug-resistant tuberculosis (MDR-TB), which is a serious form of tuberculosis that does not respond to standard TB medications. This test is part of therapeutic drug monitoring, which means your healthcare team is checking to make sure you have the right amount of medicine in your body—not too little (which could make treatment ineffective) and not too much (which could cause side effects).

This test may be ordered as part of a routine checkup, to help diagnose symptoms such as fatigue, weakness, fever, or unusual bruising, to monitor an ongoing condition like anemia or infection, or to see how treatments such as chemotherapy are affecting your blood cells over time.

Your doctor may order this test for several important reasons. First, it helps confirm that the amount of bedaquiline in your blood is sufficient to fight the tuberculosis bacteria effectively. Second, it helps prevent potential side effects that can occur when drug levels become too high, such as liver problems or heart rhythm abnormalities. Third, it ensures that you are taking your medication correctly and that your body is absorbing it properly. Finally, this test may be used periodically throughout your treatment to monitor the drug levels and make any necessary adjustments to your dosage.

The test is done with a simple blood draw. A healthcare professional cleans the skin at the inside of your elbow, wraps a band around your upper arm, and inserts a small needle into a vein to collect a sample into a tube. The whole procedure usually takes only a few minutes.

A healthcare professional will draw a small sample of blood from a vein in your arm, typically in the morning before you take your daily dose of bedaquiline. This timing is important because it measures the lowest level of the drug in your system (called the "trough" level), which helps your doctor accurately assess whether your current dosage is appropriate. The blood sample is then sent to a laboratory where special equipment measures the concentration of bedaquiline. The results are usually available within a few days.

Results are compared with normal reference ranges. A low red blood cell count may suggest anemia, a high white blood cell count can point to infection or inflammation, and low platelets may affect clotting. Abnormal values do not always mean a serious problem, so your doctor will interpret them together with your symptoms and may order follow-up testing.

Your test results will show the concentration of bedaquiline in your blood. Your doctor will interpret these results based on your specific situation, including how far along you are in your treatment, your overall health, and other medications you may be taking. If your level is too low, your doctor may need to increase your dose or check that you are taking your medication properly. If your level is too high, your doctor may reduce your dose to prevent side effects. It is important to remember that the "normal" range can vary, and your doctor is the best person to explain what your specific results mean for your treatment.

This test is very safe. You may feel a brief sting when the needle goes in, and some people have mild soreness, bruising, or slight bleeding at the puncture site afterward. Serious problems such as infection or heavy bleeding are rare, but tell your care team if you take blood thinners or bleed easily.

The risks associated with this blood test are minimal and similar to any routine blood draw. You may experience slight bruising, bleeding, or soreness at the puncture site. In rare cases, fainting or infection may occur. The test itself does not carry any risks related to the medication bedaquiline—it simply measures what is already in your blood. If you have any concerns about the blood draw or about taking bedaquiline, discuss them with your healthcare provider before the test.

Reference range

Therapeutic trough range: 0.3–1.0 mg/L; optimal peak concentration (Cmax) following standard dosing: 1.5–3.0 mg/L. Levels should be interpreted in conjunction with clinical response and assessment of QTc interval.N/A

Specimen: serum

No fasting required. Trough levels should be drawn immediately before the next scheduled dose (typically 24 hours after the prior dose during loading, or per clinical protocol). Document time of last dose and time of specimen collection.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Bedaquiline is a critical medication for treating multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB). This test is clinically significant because it enables therapeutic drug monitoring (TDM), which optimizes treatment outcomes while minimizing toxicity. Bedaquiline can cause serious side effects, including hepatotoxicity (liver damage) and QT prolongation (heart rhythm changes), making regular monitoring essential. The test helps healthcare providers ensure patients achieve therapeutic drug levels that are effective against resistant TB strains while avoiding supratherapeutic concentrations that increase adverse event risk. Additionally, this monitoring is crucial for patients with altered pharmacokinetics, such as those with liver impairment, or those taking other medications that might interact with bedaquiline.

Frequently asked questions

How often do I need this test?
The frequency of bedaquiline testing depends on your individual treatment plan. Typically, your doctor may order this test when you first start taking bedaquiline to establish a baseline, and then periodically throughout your treatment—often every few weeks or months. Your healthcare provider will determine the appropriate testing schedule based on your response to treatment, any side effects you experience, and other medications you may be taking.
Do I need to fast before the test?
Your doctor will typically instruct you to have your blood drawn in the morning before you take your daily dose of bedaquiline. This is because the test usually measures the lowest drug level in your system (trough level), which is most accurately captured right before your next dose. Follow your healthcare provider's specific instructions about timing and whether fasting is necessary.
What happens if my bedaquiline level is too high?
If your test shows that your bedaquiline level is higher than expected, your doctor may take several steps. They might temporarily reduce your dose, ask you to monitor for specific symptoms, or run additional tests to check for side effects such as liver problems or heart rhythm changes. It is important not to adjust your medication without consulting your healthcare provider first.
What happens if my level is too low?
If your bedaquiline level is lower than therapeutic range, your doctor may check that you are taking your medication correctly (such as with food, as directed), may increase your dose, or investigate whether your body is not absorbing the medication properly. Low levels may mean the treatment is not effectively fighting the tuberculosis bacteria.
Can I take my bedaquiline before the blood test?
No, you should typically NOT take your bedaquiline before having this blood test unless your doctor specifically instructs otherwise. The test is usually done as a "trough" level measurement, meaning right before your next dose when the drug level is at its lowest point in your system. Taking the medication before the test would give a falsely high reading.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 15, 2026. · Read our editorial policy